CMS’s Conway in the national spotlight as two (or more) healthcare workers in one

If you’re familiar with the name Patrick H. Conway, MD, MSc, you probably know him as the chief medical officer of the Centers for Medicare and Medicaid Services and/or the lead administrator of CMS’s innovation center. But those are just his weekday jobs.

Many weekends find Conway caring for pediatric patients and training medical residents at Children’s National Medical Center.

The New York Times ran a feature on the man and his work March 29.

“On a recent Saturday, Dr. Conway, a pediatrician, examined a 5-month-old girl who had a heart defect and pneumonia, a cranky 2-year-old girl whose body was covered with a mysterious rash, and a 17-year-old patient with belly pain and an inflamed pancreas,” the paper reported before pointing out that Conway “has a say in almost every significant or controversial healthcare policy change contemplated by the Obama administration.”

Click below to read the piece, which also presents several telling doc-in-action photos.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.